Tobias Peikert

8.7k total citations
101 papers, 3.0k citations indexed

About

Tobias Peikert is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tobias Peikert has authored 101 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tobias Peikert's work include Lung Cancer Diagnosis and Treatment (21 papers), Radiomics and Machine Learning in Medical Imaging (18 papers) and Occupational and environmental lung diseases (17 papers). Tobias Peikert is often cited by papers focused on Lung Cancer Diagnosis and Treatment (21 papers), Radiomics and Machine Learning in Medical Imaging (18 papers) and Occupational and environmental lung diseases (17 papers). Tobias Peikert collaborates with scholars based in United States, France and United Kingdom. Tobias Peikert's co-authors include Ulrich Specks, Aaron S. Mansfield, Rodrigo Cartin‐Ceba, Steven R. Ytterberg, Eunhee S. Yi, Anja C. Roden, Fabien Maldonado, George Vasmatzis, Brian J. Bartholmai and Marie Christine Aubry and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Tobias Peikert

95 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tobias Peikert United States	31	2.1k	620	525	408	348	101	3.0k
Mark A. Ahlman United States	25	836 0.4×	252 0.4×	523 1.0×	571 1.4×	260 0.7×	80	2.1k
Paolo Graziano Italy	34	1.3k 0.6×	1.1k 1.8×	357 0.7×	170 0.4×	157 0.5×	162	3.1k
Katherine M. Krajewski United States	37	1.9k 0.9×	1.6k 2.6×	510 1.0×	588 1.4×	87 0.3×	134	4.4k
Richard B. Wilder United States	29	1.0k 0.5×	946 1.5×	168 0.3×	487 1.2×	129 0.4×	94	2.6k
Donna J. Lager United States	39	1.3k 0.6×	780 1.3×	375 0.7×	166 0.4×	206 0.6×	87	4.9k
Mercè Jordà United States	33	1.3k 0.7×	1.0k 1.6×	311 0.6×	278 0.7×	121 0.3×	157	3.2k
Paul E. Wakely United States	33	1.5k 0.7×	1.3k 2.1×	865 1.6×	212 0.5×	128 0.4×	221	4.6k
Mitual Amin United States	27	1.8k 0.9×	865 1.4×	242 0.5×	208 0.5×	246 0.7×	86	3.3k
Yukihiro Imai Japan	28	1.3k 0.7×	1.2k 1.9×	130 0.2×	152 0.4×	122 0.4×	203	2.8k
Jimmy J. Caudell United States	35	1.7k 0.8×	1.4k 2.3×	138 0.3×	784 1.9×	141 0.4×	157	4.0k

Countries citing papers authored by Tobias Peikert

Since Specialization

Citations

This map shows the geographic impact of Tobias Peikert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Peikert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Peikert more than expected).

Fields of papers citing papers by Tobias Peikert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Peikert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Peikert. The network helps show where Tobias Peikert may publish in the future.

Co-authorship network of co-authors of Tobias Peikert

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Peikert. A scholar is included among the top collaborators of Tobias Peikert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Peikert. Tobias Peikert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parikh, Kaushal, Faye R. Harris, Jay Mandrekar, et al.. (2024). Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for Mesothelioma. JTO Clinical and Research Reports. 5(12). 100692–100692. 1 indexed citations

Peikert, Tobias, et al.. (2024). UNEXPLAINED DYSPNEA AND HYPOXEMIA IN A PATIENT WITH PROGRESSIVE METASTATIC BREAST CANCER ON IMMUNOTHERAPY: A DIAGNOSTIC DILEMMA. CHEST Journal. 166(4). A5410–A5411.

Simard, Trevor, William R. Miranda, C. Charles Jain, et al.. (2023). Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis. Journal of the American College of Cardiology. 81(24). 2361–2373. 8 indexed citations

Kammer, Michael N., Samira Shojaee, Brent E. Heideman, et al.. (2023). Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules. CHEST Journal. 164(4). 1028–1041. 15 indexed citations

Abeykoon, Jithma P., et al.. (2023). Deep and Repeated Response to Trastuzumab Deruxtecan in a Patient With Human Epidermal Growth Factor Receptor 2–Amplified Large-Cell Neuroendocrine Carcinoma With Brain Metastases: A Case Report. JCO Precision Oncology. 7(7). e2300242–e2300242. 1 indexed citations

Massey, Shane, Michael J. Hansen, Courtney L. Erskine, et al.. (2022). Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Science Advances. 8(34). eabm8563–eabm8563. 9 indexed citations

Luo, Yung‐Hung, Han Liu, Jason A. Wampfler, et al.. (2021). Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation. Journal of Cancer Research and Clinical Oncology. 148(8). 2099–2114. 3 indexed citations

Maldonado, Fabien, Srinivasan Rajagopalan, Fenghai Duan, et al.. (2020). Validation of the BRODERS classifier (BenignversusaggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules. European Respiratory Journal. 57(4). 2002485–2002485. 22 indexed citations

Sears, Catherine R., Tobias Peikert, Jennifer D. Possick, et al.. (2019). Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 200(6). e31–e43. 96 indexed citations

10.

Mutti, Luciano, Tobias Peikert, B. W. Robinson, et al.. (2018). Scientific Advances and New Frontiers in Mesothelioma Therapeutics. Journal of Thoracic Oncology. 13(9). 1269–1283. 69 indexed citations

11.

Peikert, Tobias, Sumithra J. Mandrekar, Virginia Van Keulen, et al.. (2017). OA13.07 Intrapleural Modified Vaccine Strain Measles Virus Therapy for Patients with Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(1). S296–S296. 6 indexed citations

12.

Bois, Melanie C., Aaron S. Mansfield, William R. Sukov, et al.. (2016). c-Met expression and MET amplification in malignant pleural mesothelioma. Annals of Diagnostic Pathology. 23. 1–7. 15 indexed citations

13.

Mansfield, Aaron S., Stephen J. Murphy, Tobias Peikert, et al.. (2015). Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer. Clinical Cancer Research. 22(9). 2177–2182. 105 indexed citations

14.

Escalante, Patricio, Tobias Peikert, Virginia P. Van Keulen, et al.. (2015). Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification. American Journal of Respiratory and Critical Care Medicine. 192(5). 605–617. 22 indexed citations

15.

Maldonado, Fabien, Fenghai Duan, Sushravya Raghunath, et al.. (2015). Noninvasive Computed Tomography–based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. American Journal of Respiratory and Critical Care Medicine. 192(6). 737–744. 43 indexed citations

16.

Felts, Sara J., Virginia P. Van Keulen, Adam D. Scheid, et al.. (2015). Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patients. Cancer Immunology Immunotherapy. 64(11). 1437–1447. 4 indexed citations

17.

Johnson, Geoffrey B., et al.. (2014). B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis. European Respiratory Journal. 44(Suppl 58). 4636–4636. 1 indexed citations

18.

Hoeppner, Luke H., Ying Wang, Anil Kumar Sharma, et al.. (2014). Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells. Molecular Oncology. 9(1). 270–281. 73 indexed citations

19.

Maldonado, Fabien, Jennifer M. Boland, Sushravya Raghunath, et al.. (2013). Noninvasive Characterization of the Histopathologic Features of Pulmonary Nodules of the Lung Adenocarcinoma Spectrum using Computer-Aided Nodule Assessment and Risk Yield (CANARY)—A Pilot Study. Journal of Thoracic Oncology. 8(4). 452–460. 53 indexed citations

20.

Peikert, Tobias, Bijayee Shrestha, Marie Christine Aubry, et al.. (2012). Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease. International Journal of Rheumatology. 2012. 1–7. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact